Page last updated: 2024-08-21

erythromycin and Torsade de Pointes

erythromycin has been researched along with Torsade de Pointes in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	25 (53.19)	18.2507
2000's	15 (31.91)	29.6817
2010's	5 (10.64)	24.3611
2020's	2 (4.26)	2.80

Authors

Authors	Studies
Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Könemann, H; Rath, B; Reinke, F; Wegner, FK; Willy, K; Wolfes, J	1
Danhaive, O; Dussart, A; Fobe, C; Moniotte, S; Piersigilli, F; Van Grambezen, B; Vo, C	1
Bögeholz, N; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Krawczyk, J	1
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M	1
Agladze, KI; Dementyeva, EV; Podgurskaya, AD; Slotvitsky, MM; Tsvelaya, VA; Valetdinova, KR	1
Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L	1
Bitzer, M; Gregor, M; Riessen, R; Werner, CR	1
Coker, SJ; Farkas, A	1
Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N	1
Al-Khatib, SM; Allen LaPointe, NM; Califf, RM; Curtis, LH; Dans, PE; Hutchison, S; Schulman, KA; Sendersky, V; Usdin Yasuda, S; Woosley, RL; Wright, A; Østbye, T	1
Juurlink, DN; Liu, BA	1
de Leon-Casasola, OA; Harris, JD	1
Crimin, K; Engtrakul, J; Fermini, B; Fossa, AA; O'Donnell, J; Wisialowski, T	1
Beckmann, BM; Hinterseer, M; Irlbeck, M; Kaab, S; Ney, L; Pfeufer, A; Steinbeck, G	1
Breithardt, G; Bruch, C; Eckardt, L; Engelen, MA; Fleischer, D; Haverkamp, W; Milberg, P; Mönnig, G; Osada, N; Stypmann, J	1
Brunckhorst, CB	1
Itoh, M; Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H	1
Itoh, Z; Kato, A; Kimura, K; Mizoguchi, K; Omura, S; Suzuki, M; Tabo, M; Takanashi, H	1
Ciummo, PE; Katz, NL	1
Guslits, B; MacDonald, LL; Orban, Z; Peters, MA	1
Windle, J; Wong, CB	1
Drew, BJ; Ide, B	1
Roden, DM	1
Bruschetta, HR; Guzman, E; Niarchos, AP; Parente, TF; Paris, DG	1
Pochop, C; Rezkalla, MA	1
Barold, SS; Brandriss, MW; Richardson, WS	1
Gully, C; Riem, R	1
Biglin, KE; Constance, TD; Faraon, MS; Lieh-Lai, M	1
de Koning, J; Hamer, B; Thompson, J; van der Hoeven, H	1
Blake, K; Goss, JE; Ramo, BW	1
Berger, LS; Buffa, SD; Gitler, B	1
Gardner, SF; Granberry, MC	1
Chang, MS; Chen, SA; Chiang, CE; Hsieh, MH; Lee, SH; Tai, CT; Wen, ZC	1
Chennareddy, SB; Karim, MY; Kudesia, V; Siddique, M	1
Antzelevitch, C; Sun, ZQ; Yan, GX; Zhang, ZQ	1
Fazekas, T; Lengyel, C; Várkonyi, T	1
Hussain, KM; Katapadi, K; Katapadi, M; Kostandy, G; Schifter, D	1
Vogt, AW; Zollo, RA	1
Fazekas, T; Krassói, I; Lengyel, C; Papp, JG; Varró, A	1
Pasco, J	1
Borggrefe, M; Breithardt, G; Clague, JR; Eckardt, L; Haverkamp, W; Johna, R; Mertens, H	1
Bradley, K; Kdesh, A; Manthous, CA; McPherson, CA; Yasick, D; Yaylali, Y	1
Shaikh, WA	1
Cox, BF; Gintant, GA; Limberis, JT; McDermott, JS; Wegner, CD	1
Koh, TW	1
Guidet, B; Haziza, F; Offenstadt, G; Staikowsky, F; Vassal, T	1

Reviews

7 review(s) available for erythromycin and Torsade de Pointes

Article	Year
Torsade de pointes. Clinical cardiology, 1993, Volume: 16, Issue:9 Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Dogs; Electrocardiography; Erythromycin; Heart Rate; Histamine Antagonists; Humans; Long QT Syndrome; Torsades de Pointes	1993
Torsades de pointes induced by erythromycin and terfenadine. The American journal of emergency medicine, 1994, Volume: 12, Issue:6 Topics: Drug Therapy, Combination; Electrocardiography; Erythromycin; Female; Humans; Lidocaine; Magnesium; Middle Aged; Terfenadine; Torsades de Pointes	1994
Erythromycin induced Torsades de Pointes: case report and review of the literature. South Dakota journal of medicine, 1994, Volume: 47, Issue:5 Topics: Aged; Aged, 80 and over; Electrocardiography; Electrophysiology; Erythromycin; Female; Humans; Infusions, Intravenous; Torsades de Pointes	1994
Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:6 Topics: Adult; Erythromycin; Female; Humans; Long QT Syndrome; Pneumonia; Torsades de Pointes	1994
Torsades de pointes induced by erythromycin. Chest, 1994, Volume: 105, Issue:2 Topics: Aged; Aged, 80 and over; Erythromycin; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Respiratory Tract Infections; Torsades de Pointes	1994
Erythromycin-induced polymorphous ventricular tachycardia with normal QT interval. American heart journal, 1996, Volume: 132, Issue:3 Topics: Adult; Anti-Bacterial Agents; Electrocardiography; Erythromycin; Humans; Male; Tachycardia, Ventricular; Torsades de Pointes	1996
[Access of torsades de pointes in Legionnaires' disease: an uncommon adverse effect of erythromycin]. Revue de pneumologie clinique, 1991, Volume: 47, Issue:2 Topics: Aged; Erythromycin; Humans; Infusions, Intravenous; Legionnaires' Disease; Male; Torsades de Pointes	1991

Trials

1 trial(s) available for erythromycin and Torsade de Pointes

Article	Year
The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective. Journal of the Indian Medical Association, 2000, Volume: 98, Issue:7 Topics: Cardiovascular Diseases; Drug Interactions; Electrocardiography; Erythromycin; Female; Histamine H1 Antagonists; Humans; Male; Rhinitis, Allergic, Seasonal; Terfenadine; Torsades de Pointes	2000

Other Studies

39 other study(ies) available for erythromycin and Torsade de Pointes

Article	Year
Propofol abolishes torsade de pointes in different models of acquired long QT syndrome. Scientific reports, 2020, 07-22, Volume: 10, Issue:1 Topics: Action Potentials; Animals; Disease Models, Animal; Electrocardiography; Erythromycin; Heart; Heart Ventricles; Propofol; Rabbits; Risk; Torsades de Pointes	2020
Torsade de pointe due to QT prolongation following erythromycin administration in a preterm infant. Acta cardiologica, 2022, Volume: 77, Issue:7 Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Infant, Newborn; Infant, Premature; Long QT Syndrome; Pregnancy; Tachycardia; Torsades de Pointes; Ureaplasma Infections	2022
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome. Journal of cardiovascular electrophysiology, 2018, Volume: 29, Issue:3 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Dantrolene; Disease Models, Animal; Electrocardiography; Erythromycin; Heart Rate; Heart Ventricles; Isolated Heart Preparation; Long QT Syndrome; Rabbits; Ryanodine Receptor Calcium Release Channel; Time Factors; Torsades de Pointes; Veratridine	2018
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018, 10-01, Volume: 20, Issue:10 Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antazoline; Anti-Bacterial Agents; Arrhythmias, Cardiac; Disease Models, Animal; Erythromycin; Histamine H1 Antagonists; Isolated Heart Preparation; Long QT Syndrome; Membrane Transport Modulators; Pinacidil; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Fibrillation	2018
The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing. Cardiovascular toxicology, 2019, Volume: 19, Issue:6 Topics: Action Potentials; Animals; Animals, Newborn; Anti-Bacterial Agents; Cardiotoxicity; Cell Line; Erythromycin; Heart Rate; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Risk Assessment; Time Factors; Torsades de Pointes; Toxicity Tests; Voltage-Sensitive Dye Imaging	2019
Macrolides use and the risk of sudden cardiac death. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:6 Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes	2016
[Unexpected complication following esophageal variceal hemorrhage - Case 2/2011]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:5 Topics: Amiodarone; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Electric Countershock; Electrocardiography, Ambulatory; Erythromycin; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Liver Cirrhosis, Alcoholic; Long QT Syndrome; Male; Middle Aged; Peptide Fragments; Recurrence; Risk Factors; Tachycardia; Torsades de Pointes	2011
Limited induction of torsade de pointes by terikalant and erythromycin in an in vivo model. European journal of pharmacology, 2002, Aug-02, Volume: 449, Issue:1-2 Topics: Action Potentials; Adrenergic alpha-1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Blood Gas Analysis; Blood Pressure; Body Temperature; Chromans; Electrocardiography; Erythromycin; Heart Rate; Male; Piperidines; Quaternary Ammonium Compounds; Rabbits; Torsades de Pointes	2002
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1 Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes	2002
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. The American journal of medicine, 2003, Feb-01, Volume: 114, Issue:2 Topics: Adult; Aged; Amitriptyline; Anti-Bacterial Agents; Anti-Infective Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clarithromycin; Cohort Studies; Drug Prescriptions; Drug Synergism; Erythromycin; Female; Fluoxetine; Heart Conduction System; Humans; Male; Middle Aged; Ofloxacin; Outpatients; Polypharmacy; Torsades de Pointes; United States	2003
Drugs and the QT interval - caveat doctor. The New England journal of medicine, 2004, Sep-09, Volume: 351, Issue:11 Topics: Anti-Bacterial Agents; Cytochrome P-450 Enzyme Inhibitors; Death, Sudden, Cardiac; Drug Interactions; Electrocardiography; Erythromycin; Humans; Torsades de Pointes	2004
Oral erythromycin and the risk of sudden death. The New England journal of medicine, 2005, Jan-20, Volume: 352, Issue:3 Topics: Anti-Bacterial Agents; Cytochrome P-450 Enzyme Inhibitors; Death, Sudden, Cardiac; Drug Interactions; Electrocardiography; Erythromycin; Humans; Methadone; Narcotics; Torsades de Pointes	2005
Antibiotic increases risk of sudden death. Health news (Waltham, Mass.), 2005, Volume: 11, Issue:1 Topics: Anti-Bacterial Agents; Death, Sudden, Cardiac; Drug Interactions; Drug Therapy, Combination; Erythromycin; Humans; Torsades de Pointes	2005
Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:1 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Aza Compounds; Cell Line; Dose-Response Relationship, Drug; Erythromycin; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Guinea Pigs; Heart Rate; Humans; Ketolides; Moxifloxacin; Quinolines; Risk Factors; Torsades de Pointes	2006
Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman. British journal of anaesthesia, 2006, Volume: 97, Issue:2 Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Echocardiography; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Female; Fluconazole; Humans; Hypokalemia; Long QT Syndrome; Mutation; Recurrence; Respiratory Distress Syndrome; Torsades de Pointes; Treatment Outcome; Ventricular Dysfunction, Left	2006
Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers. Basic research in cardiology, 2007, Volume: 102, Issue:1 Topics: Action Potentials; Animals; Antibiotics, Antineoplastic; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Erythromycin; Heart Conduction System; In Vitro Techniques; Male; Rabbits; Stroke Volume; Torsades de Pointes	2007
[CME-EKG 17. Coronary heart disease and arrhythmia]. Praxis, 2007, Jun-20, Volume: 96, Issue:25-26 Topics: Aged; Coronary Disease; Diagnosis, Differential; Electrocardiography; Erythromycin; Furosemide; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypokalemia; Male; Pneumonia, Bacterial; Risk Factors; Syncope; Torsades de Pointes	2007
Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin. The Journal of toxicological sciences, 2007, Volume: 32, Issue:3 Topics: Action Potentials; Animals; Cell Line; Cisapride; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Gastrointestinal Agents; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Potassium Channel Blockers; Rabbits; Risk Assessment; Time Factors; Torsades de Pointes; Transfection	2007
Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model. The Journal of toxicological sciences, 2007, Volume: 32, Issue:3 Topics: Action Potentials; Anesthesia, General; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cisapride; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Halothane; Heart Rate; Infusions, Intravenous; Long QT Syndrome; Male; Models, Animal; Risk Assessment; Time Factors; Torsades de Pointes; Ventricular Function, Left; Ventricular Pressure	2007
Interactions and drug-metabolizing enzymes. American pharmacy, 1995, Volume: NS35, Issue:9 Topics: Adolescent; Adult; Anti-Allergic Agents; Antidepressive Agents, Second-Generation; Antifungal Agents; Binding Sites; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Enzyme Induction; Erythromycin; Female; Fluoxetine; Humans; Isoenzymes; Ketoconazole; Liver; Male; Middle Aged; Pharmaceutical Preparations; Terfenadine; Theophylline; Torsades de Pointes	1995
Erythromycin-induced cardiac toxicity. The American journal of cardiology, 1995, Apr-15, Volume: 75, Issue:12 Topics: Adult; Arrhythmia, Sinus; Bradycardia; Cardiac Complexes, Premature; Erythromycin; Female; Humans; Hypotension; Injections, Intravenous; Torsades de Pointes; Ventricular Fibrillation	1995
Erythromycin induced torsades de pointes. The Nebraska medical journal, 1995, Volume: 80, Issue:9 Topics: Erythromycin; Female; Humans; Middle Aged; Torsades de Pointes	1995
T wave alternans. Progress in cardiovascular nursing, 1994,Fall, Volume: 9, Issue:4 Topics: Electrocardiography; Erythromycin; Humans; Torsades de Pointes	1994
[Torsades de pointes caused by the association of terfenadine and erythromycin]. Annales de medecine interne, 1994, Volume: 145, Issue:4 Topics: Drug Therapy, Combination; Erythromycin; Humans; Male; Middle Aged; Terfenadine; Torsades de Pointes	1994
Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:2 Topics: Adolescent; Cardiac Output; Drug Interactions; Erythromycin; Female; Humans; Respiration, Artificial; Terfenadine; Torsades de Pointes	1994
Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia. The Netherlands journal of medicine, 1994, Volume: 44, Issue:4 Topics: Aged; Erythromycin; Female; Humans; Legionnaires' Disease; Torsades de Pointes; Ventricular Fibrillation	1994
Torsades de pointes associated with astemizole (Hismanal) therapy. Archives of internal medicine, 1993, Dec-13, Volume: 153, Issue:23 Topics: Aged; Aged, 80 and over; Astemizole; Erythromycin; Female; Humans; Hypokalemia; Torsades de Pointes	1993
Erythromycin monotherapy associated with torsade de pointes. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Care; Electrocardiography; Erythromycin; Female; Humans; Male; Middle Aged; Torsades de Pointes	1996
Drug-induced torsades de pointes in one patient with congenital long QT syndrome. International journal of cardiology, 1996, Apr-19, Volume: 54, Issue:1 Topics: Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Astemizole; Cardiac Pacing, Artificial; Electrocardiography; Erythromycin; Female; Histamine H1 Antagonists; Humans; Long QT Syndrome; Propranolol; Rhinitis; Torsades de Pointes	1996
Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. Journal of the American College of Cardiology, 1996, Volume: 28, Issue:7 Topics: Action Potentials; Animals; Anti-Bacterial Agents; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Endocardium; Erythromycin; Heart; Heart Ventricles; In Vitro Techniques; Long QT Syndrome; Male; Microelectrodes; Myocardium; Patch-Clamp Techniques; Pericardium; Potassium Channels; Torsades de Pointes	1996
[Erythrocyte-induced "torsade de pointes" ventricular tachycardia]. Orvosi hetilap, 1997, Apr-20, Volume: 138, Issue:16 Topics: Clopamide; Dose-Response Relationship, Drug; Electrocardiography; Erythromycin; Female; Humans; Hypokalemia; Middle Aged; Potassium; Tachycardia, Ventricular; Torsades de Pointes	1997
A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report. Angiology, 1997, Volume: 48, Issue:9 Topics: Anti-Bacterial Agents; Electrocardiography; Erythromycin; Female; Heart Conduction System; Heart Rate; Humans; Middle Aged; Torsades de Pointes	1997
Long Q-T syndrome associated with oral erythromycin used in preoperative bowel preparation. Anesthesia and analgesia, 1997, Volume: 85, Issue:5 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Erythromycin; Female; Humans; Jejunoileal Bypass; Long QT Syndrome; Preoperative Care; Torsades de Pointes	1997
Suppression of erythromycin-induced early afterdepolarizations and torsade de pointes ventricular tachycardia by mexiletine. Pacing and clinical electrophysiology : PACE, 1998, Volume: 21, Issue:1 Pt 2 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Dogs; Electric Stimulation; Erythromycin; Female; Humans; In Vitro Techniques; Mexiletine; Middle Aged; Purkinje Fibers; Syncope; Torsades de Pointes	1998
What has the patient been taking? Australian family physician, 1998, Volume: 27, Issue:6 Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlorothiazide; Cimetidine; Diagnosis, Differential; Diuretics; Electrocardiography; Electrolytes; Erythromycin; Female; Histamine H1 Antagonists; Humans; Long QT Syndrome; Sodium Chloride Symporter Inhibitors; Terfenadine; Torsades de Pointes	1998
Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:3 Topics: Animals; Bradycardia; Electrocardiography; Erythromycin; Hypokalemia; In Vitro Techniques; Male; Quaternary Ammonium Compounds; Rabbits; Sotalol; Torsades de Pointes	1998
Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia. Southern medical journal, 1999, Volume: 92, Issue:12 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Erythromycin; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Torsades de Pointes	1999
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:5 Topics: Action Potentials; Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cisapride; Dogs; Erythromycin; Female; Fluoroquinolones; Imidazoles; In Vitro Techniques; Indoles; Long QT Syndrome; Male; Models, Biological; Moxifloxacin; Perfusion; Piperazines; Purkinje Fibers; Quinolines; Sotalol; Swine; Torsades de Pointes	2001
Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration. Pacing and clinical electrophysiology : PACE, 2001, Volume: 24, Issue:10 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antithyroid Agents; Carbimazole; Drug Interactions; Erythromycin; Female; Humans; Methimazole; Risk Factors; Torsades de Pointes	2001